NCT05219955

Brief Summary

The purpose of this research study is to better understand how stress, sleep and activity might impact caregivers' mood and brain health. This study includes a randomized experimental component where therapists will systematically deliver one of two evidence-based talk-therapy treatments. The aim is to evaluate effects on meaningful health-relevant measures including morning activation levels, depression symptoms, rumination, and aspects brain connectivity previously linked with depression. Participants will complete surveys about their caregiving experiences, health, and mood, undergo an MRI, and wear an actigraphy watch that measures activity levels throughout the day and when sleeping.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Jul 2022Jun 2027

First Submitted

Initial submission to the registry

January 21, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

July 15, 2022

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

4.5 years

First QC Date

January 21, 2022

Last Update Submit

May 15, 2026

Conditions

Keywords

DepressionCaregivingLate-LifeMorningness

Outcome Measures

Primary Outcomes (7)

  • Change from baseline in rumination at 6-months

    Rumination will be measured using the rumination subscale of the Behavioral Activation Scale for Depression (BASD). There is a minimum possible score of 0 and a maximum possible score of 24 with higher scores indicating higher \[worse\] rumination. This measure will be accessed via Ecological Momentary Assessment (EMA). A link will be sent to participant's mobile device by text message cuing participants to respond

    Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)

  • Change from baseline in depressive symptoms at 6-months

    Depression will be measured using the Patient Health Questionnaire (PHQ-9). There is a minimum possible score of 0 and a maximum possible score of 27 with higher scores indicating higher \[worse\] depression.

    Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)

  • Change from baseline in anxiety symptoms at 6-months

    Anxiety will be measured using the Generalized Anxiety Disorder 7-Item Scale (GAD-7). There is a minimum possible score of 0 and a maximum possible score of 21 with higher scores indicating higher \[worse\] anxiety.

    Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)

  • Change in objective Morning Activation Deficits (MADs) over 1 week

    Morning activation deficits (MADs), a common component of depression measurable as actigraphy assessed morning inactivity.

    Continuously for up to 1-week at baseline

  • Change in self-report Morning Activation Deficits (MADs) at 6-months

    Morning Activation Deficits (MADs) will be assessed using the Composite Morningness Questionnaire (CMQ). There is a minimum possible score of 13 and a maximum possible score of 55 with higher scores indicating a higher degree or morningness.

    Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)

  • Change in resting-state connectivity at 6-weeks

    Resting connectivity of the amygdala and ventral posterior cingulate cortex (PCC) structures will be measured by brain imaging conducted with a 7 Tesla scanner

    Baseline and 6-weeks

  • Change in neurological response to rumination cues at 6 weeks

    Rumination-related brain activation in the Limbic (amygdala), default mode network (DMN), ventral posterior cingulate cortex (PCC), and Frontal Parietal Control Network (FPCN) will be measured by brain imaging conducted with a 7 Tesla scanner.

    Baseline and 6-weeks

Secondary Outcomes (7)

  • Change in self-report nocturnal mentation at 6-months

    Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)

  • Change in self-report reward anticipation at 6-months

    Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)

  • Change in self-report apathy at 6-months

    Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)

  • Change in morning light exposure at 6-weeks

    Baseline and 6-weeks

  • Change in cognitive functioning at 6-weeks

    Baseline and 6-weeks

  • +2 more secondary outcomes

Study Arms (2)

Active condition (SAMM Protocol)

EXPERIMENTAL

The goal of the SAMM protocol is to increase morning activity engagement over a 6-week period. Participants in this condition will review their morning routine, and make a list of potential morning activities to add. They will choose one activity and develop a plan for doing it. Each day, participants are asked to track if they do the morning activity plan. If unsuccessful, at weekly follow-ups, participants are asked to refine their plan or make a new one.

Behavioral: Morning Action Plan ExecutionBehavioral: Activity Strategy-based Session with TherapistBehavioral: Advance sleep-wake time

Attention-matched supportive control condition

ACTIVE COMPARATOR

Participants in this condition will receive sessions in the same number and duration as the SAMM experimental condition. Therapists will create a comfortable environment by demonstrating interest, empathy, and acceptance without judgment. Caregivers will be encouraged to talk about stressors they experience, providing an opportunity to voice and self-address their problems. In this control condition, therapists will not deliver any particular strategy except for active listening and referring to the educational materials.

Behavioral: Attention-based Session with Therapist

Interventions

Each day, participants are asked to track if they do the morning activity plan.

Active condition (SAMM Protocol)

Participants will meet weekly with a trained therapist to discuss their prescribed activity plan. If unsuccessful, at weekly follow-ups, participants are asked to refine their plan or make a new one. Each session lasts about 30-45 minutes.

Active condition (SAMM Protocol)

Participants will meet weekly with trained a therapist to talk about stressors they experience, providing an opportunity to voice and self-address their problems. In this control condition, therapists will not deliver any particular strategy except for active listening and referring to the educational materials

Attention-matched supportive control condition

Some participants will be asked to adjust their sleep schedule to accommodate morning activity engagement by introducing or altering mechanisms known promote early rising (i.e., light exposure, reward and processes, etc.)

Active condition (SAMM Protocol)

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 55 years or older.
  • Provide at least 15 hours/week of unpaid care to a patient with a dementia diagnosis.
  • Reporting stress or strain delivering care
  • No or stable pharmacotherapy for depression
  • Meets screening definition for having morning activation difficulty or a definite morning type per the Composite Morningness Questionnaire (CMQ)

You may not qualify if:

  • Unsafe or unable to undergo MRI
  • Active Cognitive Behavioral Therapy for mood or insomnia
  • Probable dementia diagnosis
  • Deadly illness or plans to leave the study area
  • Current active substance use disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Western Behavioral Health

Pittsburgh, Pennsylvania, 15213, United States

RECRUITING

MeSH Terms

Conditions

DepressionCaregiver Burden

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorStress, Psychological

Study Officials

  • Stephen F Smagula, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sara Sellars, MA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychiatry

Study Record Dates

First Submitted

January 21, 2022

First Posted

February 2, 2022

Study Start

July 15, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

May 19, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations